Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between right ventricular systolic pressure and adverse outcomes following gastrointestinal endoscopy: a retrospective cohort study.

British journal of anaesthesia·2026
Same author

Pain Scores and Opioid Consumption after Robotic-assisted Abdominal Surgery: A Single Centre Historical Cohort Study.

Anaesthesia, critical care & pain medicine·2025
Same author

Jet Nebulization During Mechanical Ventilation: Mass Balance Analysis.

Respiratory care·2025
Same author

The Diagnostic Performance of the Cellavision DC-1 Digital Morphology Analyser on Leukaemia Samples.

Diagnostics (Basel, Switzerland)·2025
Same author

High-Flow Nasal Aerosol Therapy; Regional Aerosol Deposition and Airway Responsiveness.

Journal of aerosol medicine and pulmonary drug delivery·2024
Same author

Reply to Henry and Tsuda.

Journal of applied physiology (Bethesda, Md. : 1985)·2024

Related Experiment Video

Updated: Jul 28, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.8K

In Vitro Model for Analysis of High-Flow Aerosol Delivery During Continuous Nebulization.

Michael McPeck1, Jane Moon1, Jeyanthan Jayakumaran1

  • 1Pulmonary, Critical Care and Sleep Medicine Division, Department of Medicine, Stony Brook University Medical Center, Stony Brook, New York.

Respiratory Care
|May 30, 2023
PubMed
Summary

This study developed an anatomical model to track aerosol delivery via high-flow nasal cannula continuous nebulization. The nasal interface caused significant aerosol loss, with differences observed between nebulizer technologies.

Keywords:
aerosolcontinuous nebulizationhigh-flow nasal cannulanasal deposition

More Related Videos

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

4.3K
Use of Capillary Aerosol Generator in Continuous Production of Controlled Aerosol for Non-Clinical Studies
08:33

Use of Capillary Aerosol Generator in Continuous Production of Controlled Aerosol for Non-Clinical Studies

Published on: April 12, 2022

3.6K

Related Experiment Videos

Last Updated: Jul 28, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.8K
Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

4.3K
Use of Capillary Aerosol Generator in Continuous Production of Controlled Aerosol for Non-Clinical Studies
08:33

Use of Capillary Aerosol Generator in Continuous Production of Controlled Aerosol for Non-Clinical Studies

Published on: April 12, 2022

3.6K

Area of Science:

  • Respiratory medicine
  • Biomedical engineering
  • Pharmacokinetics

Background:

  • Understanding aerosol delivery via high-flow nasal cannula (HFNC) with continuous nebulization is crucial for optimizing respiratory treatments.
  • Previous methods lacked the precision to quantify real-time aerosol fate and circuit losses.
  • Anatomical modeling offers a controlled environment to study these complex delivery dynamics.

Purpose of the Study:

  • To develop and validate an open-source anatomical model for assessing aerosol delivery during HFNC continuous nebulization.
  • To quantify aerosol losses within the delivery circuit, particularly at the nasal interface.
  • To compare the performance of different nebulizer technologies (breath-enhanced jet nebulizer vs. vibrating mesh nebulizer) and their responsiveness to infusion rates.

Main Methods:

  • Anatomical model creation: A 3D-printed head and face structure with a nasal airway cast, connected to a piston ventilator.
  • Mass balance experiments: Saline with Technetium-99m infused for 1 hour, with aerosol delivery measured by a gamma ratemeter at the hypopharynx.
  • Variable testing: Continuous nebulization assessed at varying infusion rates (10-40 mL/h) and gas flows (60 L/min) using BEJN and vibrating mesh nebulizers.

Main Results:

  • The primary site of aerosol loss was the nasal interface, accounting for approximately 25% of the delivered aerosol.
  • Significant differences in circuit component deposition were observed between the two nebulizer types.
  • While both nebulizers showed increased aerosol delivery with higher infusion rates, the BEJN demonstrated a substantially greater delivery capacity at 60 L/min gas flow.

Conclusions:

  • The developed anatomical model accurately identifies aerosol loss sites during HFNC continuous nebulization.
  • This in vitro system provides a realistic platform for evaluating aerosol delivery parameters, including nebulizer technology and infusion rates.
  • Real-time analysis enables quantification of the impact of multiple variables on aerosol delivery efficiency.